title: Impact of liver transplantation on renal function of patients with congenital hepatic fibrosis associated with autosomal recessive polycystic kidney disease.
abstract: Congenital hepatic fibrosis (CHF) is an uncommon autosomal recessive malformation. It may be associated with extrahepatic manifestations such as polycystic kidney disease. The main consequence is portal hypertension and bleeding from varices. Despite liver transplantation as a therapeutic option for this patient, long-term impact of liver transplantation on renal functions of patients with autosomal recessive polycystic kidney disease with associated liver disease is not well known. In this study, we aimed to analyze the patient's renal function after liver transplantation by creatinine clearance, glomerular filtration rate, and renal resistive indexes. Between March 1997 and September 2002, three of 50 orthotopic liver transplantation (OLT) were performed because of CHF associated with ARPKD at Ege University Organ Transplantation and Research Center. Baseline immunosuppression consisted of prednisone and cyclosporine A (CSA). The mean follow-up of the patients was 2.1 yr. Blood urea and creatinine levels were decreased after operation in all patients and remained within the normal range at the sixth and 12th month, whereas the level of the third patient were increased at the 18th month. RRI values of patients were not found different at the sixth month whereas, RRI values of patients were decreased at the 12th month and remained unchanged at the 18th month of follow-up. During the study period hypertension developed in one patient at the 16th month and resolved with antihypertensive treatment and decreasing dosage of CSA. Kidney function has remained satisfactory in all of the patients despite the use of cyclosporine. OLT can provide good survival in patients with CHF associated with ARPKD.
authors.affiliation: Pediatric Gastroenterology, Hepatology and Nutrition, Ege University School of Medicine, Organ Transplantation and Research Center, Izmir, Turkey. arikan@med.ege.edu.tr
authors.forename: Cigdem
authors.initials: C
authors.lastname: Arikan
authors.forename: Funda
authors.initials: F
authors.lastname: Ozgenc
authors.forename: Sezin Asik
authors.initials: SA
authors.lastname: Akman
authors.forename: Murat
authors.initials: M
authors.lastname: Kilic
authors.forename: Yaman
authors.initials: Y
authors.lastname: Tokat
authors.forename: Rasit Vural
authors.initials: RV
authors.lastname: Yagci
authors.forename: Sema
authors.initials: S
authors.lastname: Aydogdu
mesh_terms: D000293:Adolescent; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D005919:Glomerular Filtration Rate; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000503:physiopathology*; D008103:Liver Cirrhosis / Q000151:congenital* / Q000601:surgery*; D016031:Liver Transplantation / Q000502:physiology*; D017044:Polycystic Kidney, Autosomal Recessive / Q000453:epidemiology / Q000503:physiopathology*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine